Eye Diseases Journals
Many eye diseases haven't any early symptoms. They'll be painless, and you'll see no change in your vision until the disease has become quite advanced. The only best thanks to protect your vision are thru regular professional eye examinations. Of course, between examinations, if you notice a change in your vision – otherwise you think your eye could also be injured in any way – contact your eye care professional immediately. Age-related degeneration (AMD) is that the physical disturbance of the middle of the
retina called the macula. Bulging eyes, or proptosis, occurs when one or both eyes protrude from the attention sockets thanks to space taking lesions likes. Cataracts are a degenerative sort of disease during which the lens gradually becomes opaque and vision mists over welling of the muscles, fat, and tissue behind the attention .In rare cases, children develop cataracts within the first few years of their lives. CMV Retinitis may be a serious
infection of the
retina that always affects people with
AIDS (Acquired Immune Deficiency Syndrome) which can also affect people with other immune disorders. Color blindness isn't actually blindness within the true sense but rather may be a chromatic vision deficiency—people who are suffering from it simply don't accept as true with most people about color matching.
High Impact List of Articles
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Data fraud in clinical trials
Stephen L George, & Marc Buyse
Clinical Trail Perspective: Clinical Investigation
-
Data fraud in clinical trials
Stephen L George, & Marc Buyse
Clinical Trail Perspective: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
Neuroblastoma drug development: from lab bench to bedside?
Louis Chesler
Interview: Clinical Investigation
-
Neuroblastoma drug development: from lab bench to bedside?
Louis Chesler
Interview: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
Relevant Topics in Clinical